IPCALABNSEIPCA Laboratories Limited· PharmaceuticalsLowNeutral
Announced Mon, 11 Aug · 17:53 IST

IPCA Laboratories Limited has informed the Exchange about Shareholders meeting-Proceedings of Meeting

Board & Shareholder Meetings View source PDF

IPCALAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Ipca Laboratories held its 75th Annual General Meeting on August 11, 2025 via video conferencing from 3:30 PM to 4:30 PM, chaired by Mr. Premchand Godha. All directors, the CFO, Company Secretary, and representatives of statutory auditors, secretarial auditors, and scrutinizer were present through video conference. The meeting covered adoption of audited standalone and consolidated financial statements for FY ended March 31, 2025, confirmation of dividend on equity shares for FY25, and re-appointment of Mr. Prashant Godha and Mr. Premchand Godha (both retiring by rotation) as directors. Two special resolutions were also proposed — alteration to the object clause of the Memorandum of Association and alteration to the interpretation clause of the Articles of Association. E-voting took place from August 7-10, 2025, and the scrutinizer's report will determine the final voting results, which will be posted on the company's website later.

Likely market impact

This is a routine regulatory filing on AGM proceedings. Shareholders should watch for the upcoming voting results announcement, particularly the dividend confirmation for FY25 and the outcome of the two special resolutions on changes to the company's constitutional documents. No material new business or strategic shifts were disclosed.